Loading...
Loading...

Meta and Microsoft in focus, as the big tech names report results. How our traders are handling the moves, and what it means for entire tech trade. Plus Eli Lilly getting hit, as the pharma stock misses estimates and slashes guidance. So are the disappointing results a sign the weight loss drug boom is slimming out?
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
CNBC's "Fast Money"